<?xml version="1.0" encoding="UTF-8"?>
<p id="Par77">Studies have shown that IL-6 levels significantly associated with the severity of COVID-19, C-reactive protein (CRP), lactate dehydrogenase (LDH), and D-dimer levels and T cell numbers, and it has been recommended that Tocilizumab, with its inhibitory effect on IL-6, may be effective in the treatment of COVID-19 [
 <xref ref-type="bibr" rid="CR71">71</xref>].
</p>
